Search

everythinglearnresearchcommunity

for

Search:↓

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Ondansetron can cause serious allergic reactions, so use it carefully.

Isoquercitrin helps hair grow by activating certain cell processes.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Inducing survivin in normal tissues can protect against radiation damage.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

TS-13 speeds up hair regrowth after chemotherapy without affecting treatment effectiveness.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Caffeine reduces radiation skin damage but doesn't affect tumor treatment.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

Upadacitinib may effectively treat alopecia areata without side effects.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.